A dried yeast fermentate selectively modulates both the luminal and mucosal gut microbiota and protects against inflammation, as studied in an integrated in vitro approach

Journal of Agricultural and Food Chemistry

Volumn 61, Issue 39, 2013, Pages 9380-9392

  Possemiers, Sam ^a   Pinheiro, Iris ^b   Verhelst, An ^b   Van Den Abbeele, Pieter ^a   Maignien, Lois ^a   Laukens, Debby ^a   Reeves, Stuart G ^c   Robinson, Larry E ^c   Raas, Thomas ^d   Schneider, Yves Jacques ^d   Van De Wiele, Tom ^a   Marzorati, Massimo ^a  

^a GHENT UNIVERSITY   (Belgium)

^b Formerly at Prodigest   (Belgium)

^c Embria Health Sciences   (United States)

^d UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Immune response; Intestinal bacteria; Prebiotic; SHIME; Yeast fermentate

Indexed keywords

ANTI-INFLAMMATORY ACTIVITY; COMMUNITY STRUCTURES; IMMUNE RESPONSE; INTESTINAL BACTERIA; MODULATING EFFECT; PREBIOTICS; PRO-INFLAMMATORY CYTOKINES; SHIME;

BACTERIA; CELL CULTURE; MEDICAL APPLICATIONS;

YEAST;

ANTIINFLAMMATORY AGENT; CYTOKINE; IMMUNOLOGIC FACTOR; PREBIOTIC AGENT;

ARTICLE; BACTERIUM ADHERENCE; BIFIDOBACTERIUM; CELL LINE; CLOSTRIDIUM; COCULTURE; DRUG ANTAGONISM; ENTEROBACTERIACEAE; FERMENTATION; GROWTH, DEVELOPMENT AND AGING; HUMAN; IMMUNOLOGY; INTESTINE CELL; LACTOBACILLACEAE; METABOLISM; MICROBIOLOGY; MONOCYTE; MUCUS; SACCHAROMYCES CEREVISIAE; SECRETION (PROCESS);

ANTI-INFLAMMATORY AGENTS; BACTERIAL ADHESION; BIFIDOBACTERIUM; CELL LINE; CLOSTRIDIUM; COCULTURE TECHNIQUES; CYTOKINES; ENTEROBACTERIACEAE; ENTEROCYTES; FERMENTATION; HUMANS; IMMUNOLOGIC FACTORS; LACTOBACILLACEAE; MONOCYTES; MUCUS; PREBIOTICS; SACCHAROMYCES CEREVISIAE;

EID: 84892963965     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf402137r     Document Type: Article

References (66)

1. MacDonald, T. T.; Monteleone, G. Immunity, inflammation, and allergy in the gut. Science 2005, 307, 1920-1925. (Pubitemid 40404695)
2. Abraham, C.; Medzhitov, R. Interactions between the host innate immune system and microbes in inflammatory bowel disease. Gastroenterology 2011, 140, 1729-1737.
3. Hotamisligil, G. S. Inflammation and metabolic disorders. Nature 2006, 444, 860-867. (Pubitemid 46024993)
4. Thoreson, R.; Cullen, J. J. Pathophysiology of inflammatory bowel disease: an overview. Surg. Clin. North Am. 2007, 87, 575-585. (Pubitemid 46881077)
5. Morgan, X. C.; Tickle, T. L.; Sokol, H.; Gevers, D.; Devaney, K. L.; Ward, D. V.; Reyes, J. A.; Shah, S. A.; LeLeiko, N.; Snapper, S. B.; Bousvaros, A.; Korzenik, J.; Sands, B. E.; Xavier, R. J.; Huttenhower, C. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 1186, 13, R79.
6. Moyad, M. A.; Robinson, L. E.; Zawada, E. T.; Kittelsrud, J.; Chen, D. G.; Reeves, S. G.; Weaver, S. Immunogenic yeast-based fermentate for cold/flu-like symptoms in nonvaccinated individuals. J. Altern. Complement. Med. 2010, 16, 213-218.
7. Moyad, M. A.; Robinson, L. E.; Kittelsrud, J. M.; Reeves, S. G.; Weaver, S. E.; Guzman, A. I.; Bubak, M. E. Immunogenic yeast-based fermentation product reduces allergic rhinitis-induced nasal congestion: a randomized, double-blind, placebo-controlled trial. Adv. Ther. 2009, 26, 795-804.
8. Jensen, G. S.; Patterson, K. M.; Barnes, J.; Schauss, A. G.; Beaman, R.; Reeves, S. G.; Robinson, L. E. A double-blind placebo-controlled, randomized pilot study: consumption of a high-metabolite immunogen from yeast culture has beneficial effects on erythrocyte health and mucosal immune protection in healthy subjects. Open Nut. J. 2008, 2, 68-75.
9. Jensen, G. S.; Hart, A. N.; Schauss, A. G. An antiinflammatory immunogen from yeast culture induces activation and alters chemokine receptor expression on human natural killer cells and B lymphocytes in vitro. Nutr. Res. (N.Y.) 2007, 27, 327-335. (Pubitemid 46962176)
10. Jensen, G. S.; Patterson, K. M.; Yoon, I. Yeast culture has antiinflammatory effects and specifically activates NK cells. Comp. Immunol. Microbiol. Infect. Dis. 2008, 31, 487-500.
11. Nakashimada, Y.; Michinaka, A.; Watanabe, K.; Nishio, N.; Fujii, T. Brewer's yeast cell wall affects microbiota composition and decreases Bacteroides fragilis populations in an anaerobic gut intestinal model. J. Biosci. Bioeng. 2011, 111, 178-184.
12. Price, K. L.; Totty, H. R.; Lee, H. B.; Utt, M. D.; Fitzner, G. E.; Yoon, I.; Ponder, M. A.; Escobar, J. Use of Saccharomyces cerevisiae fermentation product on growth performance and microbiota of weaned pigs during Salmonella infection. J. Anim. Sci. 2010, 88, 3896-3908.
13. Marzorati, M.; Possemiers, S.; Verstraete, W. The use of the SHIME-related technology platform to assess the efficacy of pre- and probiotics. AgroFood Ind. Hi-Tech 2009, 20, 50-53.
14. Chopra, D. P.; Dombkowski, A. A.; Stemmer, P. M.; Parker, G. C. Intestinal epithelial cells in vitro. Stem Cells Dev. 2010, 19, 131-141.
15. Possemiers, S.; Marzorati, M.; Verstraete, W.; Van de Wiele, T. Bacteria and chocolate: a successful combination for probiotic delivery. Int. J. Food Microbiol. 2010, 141, 97-103.
16. Van de Wiele, T.; Boon, N.; Possemiers, S.; Jacobs, H.; Verstraete, W. Prebiotic effects of chicory inulin in the simulator of the human intestinal microbial ecosystem. FEMS Microbiol. Ecol. 2004, 51, 143-153. (Pubitemid 39647647)
17. Van den Abbeele, P.; Van de Wiele, T.; Verstraete, W.; Possemiers, S. The host selects mucosal and luminal associations of coevolved gut microorganisms: a novel concept. FEMS Microbiol. Rev. 2011, 35, 681-784.
18. Molly, K.; Woestyne, M. V.; Verstraete, W. Development of a 5-step multichamber reactor as a Simulation of the Human Intestinal Microbial Ecosystem. Appl. Microbiol. Biotechnol. 1993, 39, 254-258. (Pubitemid 23134616)
19. Possemiers, S.; Verthe, K.; Uyttendaele, S.; Verstraete, W. PCR-DGGE-based quantification of stability of the microbial community in a Simulator of the Human Intestinal Microbial Ecosystem. FEMS Microbiol. Ecol. 2004, 49, 495-507. (Pubitemid 39119606)
20. Van den Abbeele, P.; Grootaert, C.; Possemiers, S.; Verstraete, W.; Verbeken, K.; Van de Wiele, T. In vitro model to study the modulation of the mucin-adhered bacterial community. Appl. Microbiol. Biotechnol. 2009, 83, 349-359.
21. Possemiers, S.; Bolca, S.; Eeckhaut, E.; Depypere, H.; Verstraete, W. Metabolism of isoflavones, lignans and prenylflavonoids by intestinal bacteria: producer phenotyping and relation with intestinal community. FEMS Microbiol. Ecol. 2007, 61, 372-383. (Pubitemid 47083930)
22. Rechner, A. R.; Smith, M. A.; Kuhnle, G.; Gibson, G. R.; Debnam, E. S.; Srai, S. K. S.; Moore, K. P.; Rice-Evans, C. A. Colonic metabolism of dietary polyphenols: Influence of structure on microbial fermentation products. Free Radical Biol. Med. 2004, 36, 212-225. (Pubitemid 38117239)
23. Sanchez, J. I.; Marzorati, M.; Grootaert, C.; Baran, M.; Van Craeyveld, V.; Courtin, C. M.; Broekaert, W. F.; Delcour, J. A.; Verstraete, W.; Van de Wiele, T. Arabinoxylan-oligosaccharides (AXOS) affect the protein/carbohydrate fermentation balance and microbial population dynamics of the simulator of human intestinal microbial ecosystem. Microb. Biotechnol. 2009, 2, 103-113.
24. Hartemink, R.; Domenech, V. R.; Rombouts, F. M. LAMVAB - a new selective medium for the isolation of lactobacilli from faeces. J. Microbiol. Methods 1997, 29, 77-84. (Pubitemid 27319830)
25. Hartemink, R.; Kok, B. J.; Weenk, G. H.; Rombouts, F. M. Raffinose-Bifidobacterium (RB) agar, a new selective medium for bifidobacteria. J. Microbiol. Methods 1996, 27, 33-43. (Pubitemid 26375862)
26. Boon, N.; Top, E. M.; Verstraete, W.; Siciliano, S. D. Bioaugmentation as a tool to protect the structure and function of an activated sludge microbial community against a 3-chloroaniline shock load. Appl. Environ. Microbiol. 2003, 69, 1511-1520. (Pubitemid 36314289)
27. Cani, P. D.; Possemiers, S.; Van de Wiele, T.; Guiot, Y.; Everard, A.; Rottier, O.; Geurts, L.; Naslain, D.; Neyrinck, A.; Lambert, D. M.; Muccioli, G. G.; Delzenne, N. M. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 2009, 58, 1091-1103.
28. Andersson, A. F.; Lindberg, M.; Jakobsson, H.; Backhed, F.; Nyren, P.; Engstrand, L. Comparative analysis of human gut microbiota by barcoded pyrosequencing. PLoS One 2008, 3, e2836.
29. De Filippo, C.; Cavalieri, D.; Di Paola, M.; Ramazzotti, M.; Poullet, J. B.; Massart, S.; Collini, S.; Pieraccini, G.; Lionetti, P. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc. Natl. Acad. Sci. U.S.A. 2010, 107, 14691-14696.
30. Marzorati, M.; Maignien, L.; Verhelst, A.; Luta, G.; Sinnott, R.; Kerckhof, F. M.; Boon, N.; Van de Wiele, T.; Possemiers, S. Barcoded pyrosequencing analysis of the microbial community in a simulator of the human gastrointestinal tract showed a colon region- specific microbiota modulation for two plant-derived polysaccharide blends. Antonie van Leeuwenhoek Int. J. Gen. Mol. Microbiol. 2013, 103, 409-420.
31. Schloss, P. D.; Westcott, S. L.; Ryabin, T.; Hall, J. R.; Hartmann, M.; Hollister, E. B.; Lesniewski, R. A.; Oakley, B. B.; Parks, D. H.; Robinson, C. J.; Sahl, J. W.; Stres, B.; Thallinger, G. G.; Van Horn, D. J.; Weber, C. F. Introducing Mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl. Environ. Microbiol. 2009, 75, 7537-7541.
32. Huse, S. M.; Welch, D. M.; Morrison, H. G.; Sogin, M. L. Ironing out the wrinkles in the rare biosphere through improved OTU clustering. Environ. Microbiol. 2010, 12, 1889-1898.
33. Haas, B. J.; Gevers, D.; Earl, A. M.; Feldgarden, M.; Ward, D. V.; Giannoukos, G.; Ciulla, D.; Tabbaa, D.; Highlander, S. K.; Sodergren, E.; Methe, B.; DeSantis, T. Z.; Petrosino, J. F.; Knight, R.; Birren, B. W. Human Microbiome, C., Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons. Genome Res. 2011, 21, 494-504.
34. Gihring, T. M.; Green, S. J.; Schadt, C. W. Massively parallel rRNA gene sequencing exacerbates the potential for biased community diversity comparisons due to variable library sizes. Environ. Microbiol. 2012, 14, 285-290.
35. Evans, J.; Sheneman, L.; Foster, J. Relaxed neighbor joining: a fast distance-based phylogenetic tree construction method. J. Mol. Evol. 2006, 62, 785-792. (Pubitemid 43847228)
36. Sheneman, L.; Evans, J.; Foster, J. A. Clearcut: a fast implementation of relaxed neighbor joining. Bioinformatics 2006, 22, 2823-2824. (Pubitemid 44742406)
37. Hamady, M.; Lozupone, C.; Knight, R. Fast UniFrac: facilitating high-throughput phylogenetic analyses of microbial communities including analysis of pyrosequencing and PhyloChip data. ISME J. 2010, 4, 17-27.
38. Lozupone, C.; Knight, R. UniFrac: a new phylogenetic method for comparing microbial communities. Appl. Environ. Microbiol. 2005, 71, 8228-8235. (Pubitemid 41803949)
39. Sambuy, Y.; De Angelis, I.; Ranaldi, G.; Scarino, M. L.; Stammati, A.; Zucco, F. The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics. Cell Biol. Toxicol. 2005, 21, 1-26. (Pubitemid 40767684)
40. Tsuchiya, S.; Kobayashi, Y.; Goto, Y.; Okumura, H.; Nakae, S.; Konno, T.; Tada, K. Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. Cancer Res. 1982, 42, 1530-1536.
41. Schwende, H.; Fitzke, E.; Ambs, P.; Dieter, P. Differences in the state of differentiation of THP-1 cells induced by phorbol ester and 1,25-dihydroxyvitamin D3. J. Leukocyte Biol. 1996, 59, 555-61. (Pubitemid 26156616)
42. Zarember, K. A.; Godowski, P. J. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J. Immunol. 2002, 168, 554-61. (Pubitemid 34049553)
43. Satsu, H.; Ishimoto, Y.; Nakano, T.; Mochizuki, T.; Iwanaga, T.; Shimizu, M. Induction by activated macrophage-like THP-1 cells of apoptotic and necrotic cell death in intestinal epithelial Caco-2 monolayers via tumor necrosis factor-alpha. Exp. Cell Res. 2006, 312, 3909-3919. (Pubitemid 44633890)
44. Marzorati, M.; Pinheiro, I.; Van den Abbeele, P.; Van de Wiele, T.; Possemiers, S. An in vitro technology platform to assess host-microbiota interactions in the gastrointestinal tract. AgroFood Ind. Hi-Tech 2012, 23, 8-11.
45. Akira, S.; Takeda, K. Toll-like receptor signalling. Nat. Rev. Immunol. 2004, 4, 499-511. (Pubitemid 38931765)
46. Duncan, S. H.; Louis, P.; Flint, H. J. Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product. Appl. Environ. Microbiol. 2004, 70, 5810-5817. (Pubitemid 39471821)
47. Medina, B.; Girard, I. D.; Jacotot, E.; Julliand, V. Effect of a preparation of Saccharomyces cerevisiae on microbial profiles and fermentation patterns in the large intestine of horses fed a high fiber or a high starch diet. J. Anim. Sci. 2002, 80, 2600-2609. (Pubitemid 41138379)
48. Metzler-Zebeli, B. U.; Zijlstra, R. T.; Mosenthin, R.; Ganzle, M. G. Dietary calcium phosphate content and oat beta-glucan influence gastrointestinal microbiota, butyrate-producing bacteria and butyrate fermentation in weaned pigs. FEMS Microbiol. Ecol. 2011, 75, 402-413.
49. Burr, G.; Hume, M.; Ricke, S.; Nisbet, D.; Gatlin, D. In vitro and in vivo evaluation of the prebiotics grobiotica (R)-A, inulin, mannanoligosaccharide, and galactooligosaccharide on the digestive microbiota and performance of hybrid striped bass (Morone chrysops x Morone saxatilis). Microb. Ecol. 2010, 59, 187-198.
50. Vinolo, M. A. R.; Rodrigues, H. G.; Nachbar, R. T.; Curi, R. Regulation of inflammation by short chain fatty acids. Nutrients 2011, 3, 858-876.
51. Breuer, R. I.; Buto, S. K.; Christ, M. L.; Bean, J.; Vernia, P.; Paoluzi, P.; Di Paolo, M. C.; Caprilli, R. Rectal irrigation with short-chain fatty acids for distal ulcerative colitis. Preliminary report. Dig. Dis. Sci. 1991, 36, 185-187.
52. Scheppach, W.; Sommer, H.; Kirchner, T.; Paganelli, G. M.; Bartram, P.; Christl, S.; Richter, F.; Dusel, G.; Kasper, H. Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology 1992, 103, 51-56.
53. Jensen, G. S.; Patterson, K. M.; Yoon, I. Nutritional yeast culture has specific anti-microbial properties without affecting healthy flora. Preliminary results. J. Anim. Feed Sci. 2008, 17, 247-252. (Pubitemid 352003985)
54. Spring, P.; Wenk, C.; Dawson, K. A.; Newman, K. E. The effects of dietary mannanoligosaccharides on cecal parameters and the concentrations of enteric bacteria in the ceca of Salmonella-challenged broiler chicks. Poult. Sci. 2000, 79, 205-211.
55. Dimitroglou, A.; Merrifield, D. L.; Moate, R.; Davies, S. J.; Spring, P.; Sweetman, J.; Bradley, G. Dietary mannan oligosaccharide supplementation modulates intestinal microbial ecology and improves gut morphology of rainbow trout, Oncorhynchus mykiss (Walbaum). J. Anim. Sci. 2009, 87, 3226-3234.
56. Pan, X.; Wu, T.; Zhang, L.; Cai, L.; Song, Z. Influence of oligosaccharides on the growth and tolerance capacity of lactobacilli to simulated stress environment. Lett. Appl. Microbiol. 2009, 48, 362-367.
57. Goodridge, H. S.; Wolf, A. J.; Underhill, D. M. β-Glucan recognition by the innate immune system. Immunol. Rev. 2009, 230, 38-50.
58. Magro, F.; Portela, F. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies. BioDrugs 2010, 24 (Suppl. 1), 3-14.
59. Fukae, J.; Amasaki, Y.; Yamashita, Y.; Bohgaki, T.; Yasuda, S.; Jodo, S.; Atsumi, T.; Koike, T. Butyrate suppresses tumor necrosis factor alpha production by regulating specific messenger RNA degradation mediated through a cis-acting AU-rich element. Arthritis Rheum. 2005, 52, 2697-2707. (Pubitemid 41369098)
60. Hamer, H. M.; Jonkers, D.; Venema, K.; Vanhoutvin, S.; Troost, F. J.; Brummer, R. J. Review article: the role of butyrate on colonic function. Aliment. Pharmacol. Ther. 2008, 27, 104-119.
61. Possemiers, S.; Bolca, S.; Grootaert, C.; Heyerick, A.; Decroos, K.; Dhooge, W.; De Keukeleire, D.; Rabot, S.; Verstraete, W.; Van de Wiele, T. The prenylflavonoid isoxanthohumol from hops (Humulus lupulus L.) is activated into the potent phytoestrogen 8-prenylnaringenin in vitro and in the human intestine. J. Nutr. 2006, 136, 1862-1867.
62. Guo, X.; Xia, X.; Tang, R.; Zhou, J.; Zhao, H.; Wang, K. Development of a real-time PCR method for Firmicutes and Bacteroidetes in faeces and its application to quantify intestinal population of obese and lean pigs. Lett. Appl. Microbiol. 2008, 47, 367-373.
63. Ramirez-Farias, C.; Slezak, K.; Fuller, Z.; Duncan, A.; Holtrop, G.; Louis, P. Effect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii. Br. J. Nutr. 2009, 101, 541-550.
64. Furet, J. P.; Firmesse, O.; Gourmelon, M.; Bridonneau, C.; Tap, J.; Mondot, S.; Dore, J.; Corthier, G. Comparative assessment of human and farm animal faecal microbiota using real-time quantitative PCR. FEMS Microbiol. Ecol. 2009, 68, 351-362.
65. Rinttila, T.; Kassinen, A.; Malinen, E.; Krogius, L.; Palva, A. Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in fecal samples by real-time PCR. J. Appl. Microbiol. 2004, 97, 1166-1177. (Pubitemid 39573940)
66. Si, W.; Gong, J.; Han, Y.; Yu, H.; Brennan, J.; Zhou, H.; Chen, S. Quantification of cell proliferation and alpha-toxin gene expression of Clostridium perf ringens in the development of necrotic enteritis in broiler chickens. Appl. Environ. Microbiol. 2007, 73, 7110-7113. (Pubitemid 350076836)